Carregant...
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
The newly emerged human coronavirus, SARS-CoV-2, had begun to spread last year and sparked worldwide. In this study, molecular docking is utilized to test some previously approved drugs against the SARS-CoV-2 nonstructural protein 15 (Nsp15). We screened 23 drugs, from which three (saquinavir, valru...
Guardat en:
| Publicat a: | Future Virol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8285111/ https://ncbi.nlm.nih.gov/pubmed/34290822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fvl-2020-0233 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|